211 related articles for article (PubMed ID: 27298334)
1. LRH-1-dependent programming of mitochondrial glutamine processing drives liver cancer.
Xu P; Oosterveer MH; Stein S; Demagny H; Ryu D; Moullan N; Wang X; Can E; Zamboni N; Comment A; Auwerx J; Schoonjans K
Genes Dev; 2016 Jun; 30(11):1255-60. PubMed ID: 27298334
[TBL] [Abstract][Full Text] [Related]
2. mTORC1 Up-Regulates GP73 to Promote Proliferation and Migration of Hepatocellular Carcinoma Cells and Growth of Xenograft Tumors in Mice.
Chen X; Wang Y; Tao J; Shi Y; Gai X; Huang F; Ma Q; Zhou Z; Chen H; Zhang H; Liu Z; Sun Q; Peng H; Chen R; Jing Y; Yang H; Mao Y; Zhang H
Gastroenterology; 2015 Sep; 149(3):741-52.e14. PubMed ID: 25980751
[TBL] [Abstract][Full Text] [Related]
3. The mTORC1/S6K1 pathway regulates glutamine metabolism through the eIF4B-dependent control of c-Myc translation.
Csibi A; Lee G; Yoon SO; Tong H; Ilter D; Elia I; Fendt SM; Roberts TM; Blenis J
Curr Biol; 2014 Oct; 24(19):2274-80. PubMed ID: 25220053
[TBL] [Abstract][Full Text] [Related]
4. mTORC1 regulates glutamine metabolism.
Cancer Discov; 2013 Jul; 3(7):OF25. PubMed ID: 23847369
[TBL] [Abstract][Full Text] [Related]
5. mTORC2 Responds to Glutamine Catabolite Levels to Modulate the Hexosamine Biosynthesis Enzyme GFAT1.
Moloughney JG; Kim PK; Vega-Cotto NM; Wu CC; Zhang S; Adlam M; Lynch T; Chou PC; Rabinowitz JD; Werlen G; Jacinto E
Mol Cell; 2016 Sep; 63(5):811-26. PubMed ID: 27570073
[TBL] [Abstract][Full Text] [Related]
6. GOT2 Silencing Promotes Reprogramming of Glutamine Metabolism and Sensitizes Hepatocellular Carcinoma to Glutaminase Inhibitors.
Li Y; Li B; Xu Y; Qian L; Xu T; Meng G; Li H; Wang Y; Zhang L; Jiang X; Liu Q; Xie Y; Cheng C; Sun B; Yu D
Cancer Res; 2022 Sep; 82(18):3223-3235. PubMed ID: 35895805
[TBL] [Abstract][Full Text] [Related]
7. Mitochondrial GCN5L1 regulates glutaminase acetylation and hepatocellular carcinoma.
Zhang T; Cui Y; Wu Y; Meng J; Han L; Zhang J; Zhang C; Yang C; Chen L; Bai X; Zhang K; Wu K; Sack MN; Wang L; Zhu L
Clin Transl Med; 2022 May; 12(5):e852. PubMed ID: 35538890
[TBL] [Abstract][Full Text] [Related]
8. Targeted disruption of fibrinogen like protein-1 accelerates hepatocellular carcinoma development.
Nayeb-Hashemi H; Desai A; Demchev V; Bronson RT; Hornick JL; Cohen DE; Ukomadu C
Biochem Biophys Res Commun; 2015 Sep; 465(2):167-73. PubMed ID: 26225745
[TBL] [Abstract][Full Text] [Related]
9. Glutaminase and glutamine synthetase activities in human cirrhotic liver and hepatocellular carcinoma.
Matsuno T; Goto I
Cancer Res; 1992 Mar; 52(5):1192-4. PubMed ID: 1346587
[TBL] [Abstract][Full Text] [Related]
10. Targeting glutaminase-mediated glutamine dependence in papillary thyroid cancer.
Yu Y; Yu X; Fan C; Wang H; Wang R; Feng C; Guan H
J Mol Med (Berl); 2018 Aug; 96(8):777-790. PubMed ID: 29942976
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of Glutaminolysis Inhibits Cell Growth via Down-regulating Mtorc1 Signaling in Lung Squamous Cell Carcinoma.
Ye X; Zhou Q; Matsumoto Y; Moriyama M; Kageyama S; Komatsu M; Satoh S; Tsuchida M; Saijo Y
Anticancer Res; 2016 Nov; 36(11):6021-6029. PubMed ID: 27793929
[TBL] [Abstract][Full Text] [Related]
12. Mitochondrial GPT2 plays a pivotal role in metabolic adaptation to the perturbation of mitochondrial glutamine metabolism.
Kim M; Gwak J; Hwang S; Yang S; Jeong SM
Oncogene; 2019 Jun; 38(24):4729-4738. PubMed ID: 30765862
[TBL] [Abstract][Full Text] [Related]
13. The mTOR/PGC-1α/SIRT3 Pathway Drives Reductive Glutamine Metabolism to Reduce Oxidative Stress Caused by ISKNV in CPB Cells.
Fu X; Li K; Niu Y; Lin Q; Liang H; Luo X; Liu L; Li N
Microbiol Spectr; 2022 Feb; 10(1):e0231021. PubMed ID: 35019690
[TBL] [Abstract][Full Text] [Related]
14. Glutaminolysis feeds mTORC1.
Durán RV; Hall MN
Cell Cycle; 2012 Nov; 11(22):4107-8. PubMed ID: 23095634
[No Abstract] [Full Text] [Related]
15. Alanyl-glutamine supplementation regulates mTOR and ubiquitin proteasome proteolysis signaling pathways in piglets.
Zhang B; Lin M; Yu C; Li J; Zhang L; Zhou P; Yang W; Gao F; Zhou G
Nutrition; 2016 Oct; 32(10):1123-31. PubMed ID: 27155955
[TBL] [Abstract][Full Text] [Related]
16. Glutaminolysis and autophagy in cancer.
Villar VH; Merhi F; Djavaheri-Mergny M; Durán RV
Autophagy; 2015; 11(8):1198-208. PubMed ID: 26054373
[TBL] [Abstract][Full Text] [Related]
17. Discovery of selective inhibitors of Glutaminase-2, which inhibit mTORC1, activate autophagy and inhibit proliferation in cancer cells.
Lee YZ; Yang CW; Chang HY; Hsu HY; Chen IS; Chang HS; Lee CH; Lee JC; Kumar CR; Qiu YQ; Chao YS; Lee SJ
Oncotarget; 2014 Aug; 5(15):6087-101. PubMed ID: 25026281
[TBL] [Abstract][Full Text] [Related]
18. Mitochondrial General Control of Amino Acid Synthesis 5 Like 1 Regulates Glutaminolysis, Mammalian Target of Rapamycin Complex 1 Activity, and Murine Liver Regeneration.
Wang L; Zhu L; Wu K; Chen Y; Lee DY; Gucek M; Sack MN
Hepatology; 2020 Feb; 71(2):643-657. PubMed ID: 31344750
[TBL] [Abstract][Full Text] [Related]
19. Glutaminase is essential for the growth of triple-negative breast cancer cells with a deregulated glutamine metabolism pathway and its suppression synergizes with mTOR inhibition.
Lampa M; Arlt H; He T; Ospina B; Reeves J; Zhang B; Murtie J; Deng G; Barberis C; Hoffmann D; Cheng H; Pollard J; Winter C; Richon V; Garcia-Escheverria C; Adrian F; Wiederschain D; Srinivasan L
PLoS One; 2017; 12(9):e0185092. PubMed ID: 28950000
[TBL] [Abstract][Full Text] [Related]
20. Heat Shock Factor 1 Epigenetically Stimulates Glutaminase-1-Dependent mTOR Activation to Promote Colorectal Carcinogenesis.
Li J; Song P; Jiang T; Dai D; Wang H; Sun J; Zhu L; Xu W; Feng L; Shin VY; Morrison H; Wang X; Jin H
Mol Ther; 2018 Jul; 26(7):1828-1839. PubMed ID: 29730197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
